openPR Logo
Press release

Immunohistochemistry (Ihc) Market Expected To Generate A Revenue Of USD 45.6 Billion By 2032 End, Globally At 6.0 % CAGR | Global Insight Services

11-15-2023 06:39 AM CET | Health & Medicine

Press release from: Global Insight Services

/ PR Agency: Global Insight Services
Immunohistochemistry (Ihc) Market Expected To Generate

The Immunohistochemistry (IHC) market has experienced substantial growth owing to the escalating prevalence of chronic diseases and the rising demand for personalized medicine. IHC techniques play a pivotal role in diagnosing various cancers and autoimmune diseases by detecting specific antigens or proteins within tissue samples. The market witnesses continuous technological advancements, including automated systems, multiplexing, and digital pathology solutions, enhancing the accuracy and efficiency of IHC assays.

Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS20875

Moreover, the expanding applications of IHC in drug development and biomarker analysis, coupled with the growing investments in research and development, are further propelling market expansion. With an increasing focus on precision medicine and the development of targeted therapies, the Immunohistochemistry market is poised to continue its upward trajectory, catering to the evolving needs of pathology laboratories, research institutions, and pharmaceutical companies worldwide.

Key Trends

One of the key trends shaping the Immunohistochemistry (IHC) market is the rapid integration of artificial intelligence (AI) and machine learning (ML) technologies. These advancements are revolutionizing IHC workflows by automating processes such as image analysis, interpretation, and quantification of staining patterns. AI-driven algorithms assist in more precise and efficient identification of biomarkers, aiding pathologists in quicker and more accurate diagnoses. The integration of AI/ML not only enhances the speed and accuracy of IHC analysis but also streamlines data management, facilitating the extraction of valuable insights from vast amounts of tissue sample data.

Read Full Research Report @ https://www.globalinsightservices.com/reports/immunohistochemistry-ihc-market/

Key Drivers

A key driver propelling the Immunohistochemistry (IHC) market is the increasing incidence of cancer and chronic diseases globally. As the prevalence of cancer continues to rise and with a growing need for accurate diagnostic tools, IHC techniques have become integral in identifying specific biomarkers and aiding in precise disease diagnosis and prognosis. The demand for personalized medicine and targeted therapies has surged, creating a robust requirement for IHC assays that can identify specific protein expressions or mutations in tissues. Moreover, ongoing research and development endeavors aimed at expanding the applications of IHC in novel disease areas and the development of companion diagnostics further fuel the market growth, highlighting IHC as a crucial tool in the arsenal against various diseases.

Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS20875

Market Segmentation : Immunohistochemistry (IHC) Market

Immunohistochemistry (IHC) Market By Product : Antibodies, Reagents, Equipment, Kits

Immunohistochemistry (IHC) Market By Application : Diagnostic application, Research application, Forensic applications

Immunohistochemistry (IHC) Market By End-user : Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Other

Immunohistochemistry (IHC) Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa

Key Players :

F. Hoffman-La Roche AG
Danaher Corporation
Agilent Technologies, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Abcam plc
Dickinson and Company
PerkinElmer, Inc.
Takara Bio, Inc.

Request for Customization @https://www.globalinsightservices.com/request-customization/GIS20875

With Global Insight Services, you receive :

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Contact Us :

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services :

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunohistochemistry (Ihc) Market Expected To Generate A Revenue Of USD 45.6 Billion By 2032 End, Globally At 6.0 % CAGR | Global Insight Services here

News-ID: 3287784 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for IHC

Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In …
What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market? The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its
Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In …
What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market? The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its
Immunohistochemistry (IHC) Market: Size, Share, Forecast, and Trends
Meticulous Research®, a leading global market research firm, has released a comprehensive new report titled "Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging]), Method (ABC, CSA, PAP), Process, Application, End User-Global Forecast to 2031." Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967 This detailed analysis highlights that the global immunohistochemistry market is on track to reach an estimated $4.08 billion by 2031,
Immunohistochemistry (IHC) Market Report 2024: Strategies And Recent Development …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2404 The Business Research Company offers in-depth market insights through Immunohistochemistry (IHC) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The immunohistochemistry (ihc) market size has grown strongly in recent years. It
Immunohistochemistry (IHC) Market Trends, Top Companies, Share, Growth And Forec …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Immunohistochemistry (IHC) Market Size, Growth Rate, And Forecast The global immunohistochemistry (IHC) market size is expected to grow from $2.23 billion in 2022 to $2.41 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery
Immunohistochemistry (IHC) Market Size, Trends, Share | Industry Growth - 2030
The most recent study offered by Acumen Research and Consulting focuses Immunohistochemistry (IHC) Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Immunohistochemistry (IHC) Market trends in order to assess its current and future potential. Our Immunohistochemistry (IHC) Market analysis also provides market participants and new entrants with a comprehensive